Bio-Techne (TECH) Misses Q1 EPS by 6c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/24/2026
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
- Chip stocks plunge, but bargain-hunters limit scale of tech rout
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- Oil prices finish 1% lower as investors focus on Hormuz flows after peace talks
- Needham Starts NeoVolta (NEOV) at Buy
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- NextEra to discuss paying about $76 per share for Dominion, Bloomberg News reports
- Campbell Soup (CPB) Declares $0.39 Quarterly Dividend; 7.7% Yield
- KKR launches Helix with over $10 billion to build AI infrastructure
Bio-Techne Releases First Quarter Fiscal 2016 Results
October 28, 2015 7:01 AM EDTMINNEAPOLIS, Oct. 28, 2015 /PRNewswire/ --Â Bio-Techne Corporation (NASDAQ: TECH) today reported its financial results for the first quarter ended September 30, 2015.
First Quarter 2016 Snapshot
Increased first quarter revenue by 4% to $112.4 million. Delivered first quarter adjusted earnings of $29.4 million, down 10% from the prior year due to FX headwinds and the timing of acquisitions in the prior year. Generated operating cash flow of $31.8 million. Continued the trend of double-digit growth in China. Achieved solid growth in the BioPharma end-markets, with a return to... MoreBio-Techne Certifies over 1,000 Antibodies for Simple Western
October 26, 2015 8:30 AM EDTMINNEAPOLIS, Oct. 26, 2015 /PRNewswire/ -- Bio-Techne Corporation announced today that its R&D Systems®, Novus Biologicals®, and ProteinSimple® brands have collaborated to certify over 1,000 antibodies for the Simple Western platform. This milestone demonstrates the power of combining premier reagent providers with innovative protein analysis systems.  The combination will enable scientists to easily transition to quantifying proteins with the Simple Western system from the tedious and semi-quantitative Western Blot method in use today.Â
"Antibody validation and reproducibility are a continuing concern in our industry," says Dr. Birte Aggeler, Director of Antibody Development at R&D Systems. "The Simple Western... More
